GF Fund Management’s Tourmaline Bio TRML Stock Holding History

GF Fund Management’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-555	Closed	-$26.5K	–	695
2025 Q3	$26.5K	Sell	555 -101	-15%	-$2.8K	﹤0.01%	457
2025 Q2	$10.5K	Hold	656	–	–	﹤0.01%	566
2025 Q1	$9.98K	Buy	656 +118	+22%	+$1.89K	﹤0.01%	565
2024 Q4	$10.9K	Buy	+538	New	+$13.5K	﹤0.01%	527

GF Fund Management's TRML Position: Q4 2025 in Review

GF Fund Management sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 555 shares — an estimated $26.5K sold.

GF Fund Management first reported a position in TRML in Q4 2024 and held it in 4 quarters. The position peaked at $26.5K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

GF Fund Management reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
GF Fund Management sold 555 Tourmaline Bio shares in Q4 2025, an estimated $26.5K.
GF Fund Management first reported a position in Tourmaline Bio in Q4 2024 and held it in 4 quarters.
GF Fund Management's Tourmaline Bio position peaked at $26.5K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on GF Fund Management's 13F filing for Q4 2025, filed 27 Jan 2026.